Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 1, Pages 4
Publisher
MDPI AG
Online
2021-12-21
DOI
10.3390/cancers14010004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook
- (2021) Evi Lianidou Molecular Oncology
- Liquid Biopsy: From Discovery to Clinical Application
- (2021) Catherine Alix-Panabières et al. Cancer Discovery
- Cystatin M/E (Cystatin 6): A Janus-Faced Cysteine Protease Inhibitor with Both Tumor-Suppressing and Tumor-Promoting Functions
- (2021) Gilles Lalmanach et al. Cancers
- Adjuvant and post-surgical treatment in high grade epithelial ovarian cancer
- (2021) Georgina E. Wood et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- USP44 Promoter Methylation in Plasma Cell-Free DNA in Prostate Cancer
- (2021) Dora Londra et al. Cancers
- SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer
- (2021) Claudia Winkler et al. JCI Insight
- BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer
- (2021) Maha Elazezy et al. Molecular Oncology
- Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- (2020) Lloreta Kerliu et al. ANNALS OF PHARMACOTHERAPY
- Newly diagnosed ovarian cancer: Which first-line treatment?
- (2020) Domenica Lorusso et al. CANCER TREATMENT REVIEWS
- USP44 is dispensable for normal hematopoietic stem cell function, lymphocyte development, and B-cell-mediated immune response in a mouse model
- (2019) Yun Hsiao Lin et al. EXPERIMENTAL HEMATOLOGY
- Recent advances in circulating nucleic acids in oncology
- (2019) A Otandault et al. ANNALS OF ONCOLOGY
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†
- (2019) N Colombo et al. ANNALS OF ONCOLOGY
- Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives
- (2019) Alka Singh et al. Frontiers in Cell and Developmental Biology
- Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy
- (2019) Kevin Shee et al. PLoS One
- FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
- (2018) Gwynn Ison et al. CLINICAL CANCER RESEARCH
- ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
- (2018) Lydia Giannopoulou et al. GYNECOLOGIC ONCOLOGY
- Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers
- (2018) Lorena Losi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SLFN11 Blocks Stressed Replication Forks Independently of ATR
- (2018) Junko Murai et al. MOLECULAR CELL
- Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer
- (2018) Ilaria Colombo et al. Drug Design Development and Therapy
- The BRCA1 Methylation and PD-L1 Expression in Sporadic Ovarian Cancer
- (2018) Xinxin Zhu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Principles of DNA methylation and their implications for biology and medicine
- (2018) Yuval Dor et al. LANCET
- Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters
- (2018) Nisreen Al-Moghrabi et al. Clinical Epigenetics
- Liquid Biopsies
- (2018) Evi Lianidou et al. GENES CHROMOSOMES & CANCER
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Application of Cell-free DNA Analysis to Cancer Treatment
- (2018) Ryan B. Corcoran et al. NEW ENGLAND JOURNAL OF MEDICINE
- CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
- (2018) Han-Wei Lin et al. Epigenomics
- Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer
- (2017) Katharina Prieske et al. Oncotarget
- RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA
- (2017) Lydia Giannopoulou et al. Oncotarget
- Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
- (2017) Maria Chimonidou et al. Oncotarget
- The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
- (2017) Martin Widschwendter et al. Genome Medicine
- Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis
- (2017) Baoli Qiao et al. Molecular Genetics & Genomic Medicine
- Methylated circulating tumor DNA in blood: power in cancer prognosis and response
- (2016) Kristina Warton et al. ENDOCRINE-RELATED CANCER
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
- (2016) Andrew P. Feinberg et al. NATURE REVIEWS GENETICS
- Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
- (2016) Antje Richter et al. Cancers
- DNA methylation changes in epithelial ovarian cancer histotypes
- (2015) Madalene A. Earp et al. GENOMICS
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs
- (2015) Vanesa Nogales et al. Oncotarget
- Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
- (2014) I Balgkouranidou et al. BRITISH JOURNAL OF CANCER
- RASSF tumor suppressor gene family: Biological functions and regulation
- (2014) Natalia Volodko et al. FEBS LETTERS
- DNA methylation markers for early detection of women’s cancer: promise and challenges
- (2014) Timo Wittenberger et al. Epigenomics
- CST6 promoter methylation in circulating cell-free DNA of breast cancer patients
- (2012) Maria Chimonidou et al. CLINICAL BIOCHEMISTRY
- SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer
- (2012) M. Chimonidou et al. CLINICAL CHEMISTRY
- Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression
- (2012) Yan-Qiu Wang et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor Cells
- (2011) M. Chimonidou et al. CLINICAL CHEMISTRY
- Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer
- (2011) Céline Montavon et al. GYNECOLOGIC ONCOLOGY
- Inactivation of O6-methyguanine-DNA methyltransferase by promoter hypermethylation: Association of epithelial ovarian carcinogenesis in specific histological types
- (2011) Hyun-Jin Roh et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- An epigenetic marker panel for screening and prognostic prediction of ovarian cancer
- (2008) Her-Young Su et al. INTERNATIONAL JOURNAL OF CANCER
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now